Processa Pharmaceuticals, Inc. (PCSA) financial statements (2021 and earlier)

Company profile

Business Address 7380 COCA COLA DRIVE
HANOVER, MD 21076
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,4166921,7412,84732
Cash and cash equivalents15,4166921,7412,84732
Receivables155 2263  
Prepaid expense  25841  
Disposal group, including discontinued operation     12
Assets held-for-sale, not part of disposal group     42
Other undisclosed current assets632316   48
Total current assets:16,2031,0072,0202,9523104
Noncurrent Assets
Property, plant and equipment091726190
Intangible assets, net (including goodwill)  10,438   
Intangible assets, net (excluding goodwill)  10,438   
Deposits noncurrent assets  6   
Other noncurrent assets9,0119,867 6  
Other undisclosed noncurrent assets    (19) 
Total noncurrent assets:9,0129,87610,46131 0
TOTAL ASSETS:25,21410,88312,4812,9833104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities546311416151742416
Accounts payable3217629251166159
Accrued liabilities2252131036413595
Taxes payable    00
Interest and dividends payable1222036441162
Debt1188802302,4491,3821,366
Due to related parties700 0  
Disposal group, including discontinued operation     300
Other undisclosed current liabilities487   230 
Total current liabilities:1,2211,1926462,6002,3542,083
Noncurrent Liabilities
Long-term debt and lease obligation78147    
Operating lease, liability78147
Liabilities, other than long-term debt5311,5322,13410  
Accounts payable and accrued liabilities   10  
Deferred tax liabilities, net2,134   
Deferred income tax liabilities5311,532
Other undisclosed noncurrent liabilities445     
Total noncurrent liabilities:1,0541,6792,13410  
Total liabilities:2,2752,8712,7802,6102,3542,083
Stockholders' equity
Stockholders' equity attributable to parent, including:22,9398,0139,701373(2,351)(1,979)
Preferred stock    00
Common stock114411
Common stock, value, subscriptions  1,800   
Additional paid in capital48,33418,99419,1214,22914,32914,322
Accumulated deficit(25,396)(10,982)(7,624)(3,859)(15,255)(14,875)
Other undisclosed stockholders' equity attributable to parent 0(3,600) (1,426)(1,428)
Total stockholders' equity:22,9398,0139,701373(2,351)(1,979)
TOTAL LIABILITIES AND EQUITY:25,21410,88312,4812,9833104

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues   55113
Revenue, net 575
Other income   5  
Cost of revenue
(Cost of Goods and Services Sold)
     (126)
Gross profit:   55(12)
Operating expenses(6,437)(3,935)(4,525)(1,802)(77)(2,679)
Other operating expense, net    (266)(292)
Other undisclosed operating loss(8,700)  (5)  
Operating loss:(15,137)(3,935)(4,525)(1,802)(337)(2,983)
Nonoperating income
(Investment Income, Nonoperating)
312185 5
Interest and debt expense(281)(37)(161)(59)(241)(236)
Loss from continuing operations before equity method investments, income taxes:(15,415)(3,961)(4,668)(1,856)(578)(3,214)
Other undisclosed income from continuing operations before income taxes    241231
Loss from continuing operations before income taxes:(15,415)(3,961)(4,668)(1,856)(337)(2,983)
Income tax benefit1,001603903  0
Loss from continuing operations:(14,414)(3,358)(3,765)(1,856)(337)(2,983)
Income (loss) from discontinued operations    1(371)
Net loss:(14,414)(3,358)(3,765)(1,856)(336)(3,354)
Net income (loss) attributable to noncontrolling interest    43(43)
Other undisclosed net income (loss) attributable to parent    (43)43
Net loss attributable to parent:(14,414)(3,358)(3,765)(1,856)(336)(3,354)
Other undisclosed net loss available to common stockholders, basic(56)(507)  (43)(43)
Net loss available to common stockholders, diluted:(14,469)(3,865)(3,765)(1,856)(379)(3,397)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(14,414)(3,358)(3,765)(1,856)(336)(3,354)
Comprehensive loss, net of tax, attributable to parent:(14,414)(3,358)(3,765)(1,856)(336)(3,354)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: